z-logo
open-access-imgOpen Access
Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic?
Author(s) -
Yakup Ergün,
Seli̇n Aktürk Esen,
Gökhan Uçar,
Yusuf Açıkgöz,
Cengiz Karaçin
Publication year - 2021
Publication title -
jco oncology practice
Language(s) - English
Resource type - Journals
eISSN - 2688-1535
pISSN - 2688-1527
DOI - 10.1200/op.20.01091
Subject(s) - pandemic , medicine , covid-19 , febrile neutropenia , neutropenia , intensive care medicine , immunology , virology , infectious disease (medical specialty) , chemotherapy , disease , outbreak

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here